Forensic Aspects of Biologic Toxins

Microbial Forensics

Volumn , Issue , 2005, Pages 131-156

  Marks, James D ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33645623867     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012088483-4/50010-X     Document Type: Chapter

References (144)

1. Centers for Disease Control (1998) Botulism in the United States, 1899–1998. Handbook for epidemiologists, clinicians, and laboratory workers Atlanta, Georgia U.S. Department of Health and Human Services, Public Health Service downloadable at http://www.bt.cdc.gov/agent/botulism/index,asp
2. MD Gill (1982) Bacterial toxins: A table of lethal amounts. Microbiol Rev 46 86-94
3. BA Herrero, AE Ecklung, CS Streett, et al. (1967) Experimental botulism in monkeys—A clinical pathological study. Exp Mol Pathol 6 84-95
4. DR Franz, LM Pitt, MA Clayton, et al. (1993) Efficacy of prophylactic and therapeutic administration of antitoxin for inhalation botulism. BR DasGupta,(Eds) Botulinum and Tetanus Neurotoxins: Neurotransmission and Biomedical Aspects New York: Plenum Press 473-476
5. EJ Schantz and EA Johnson (1992) Properties and use of botulinum toxin and other microbial neurotoxins in medicine. Microbiol Rev 56 80-99
6. AB Scott and D Suzuki (1988) Systemic toxicity of botulinum toxin by intramuscular injection in the monkey. Mov Disord 3 333-335
7. SA Arnon, R Schecter, TV Inglesby, et al. (2001) Botulinum toxin as a biological weapon. JAMA 285 1059-1070
8. N Mahant, PD Clouston and IT Lorentz (2000) The current use of botulinum toxin. J Clin Neurosci 7 389-394
9. H Sugiyama (1980) Clostridium botulinum neurotoxin. Microbiol Rev 44(3), 419-448
10. DB Lacy and RC Stevens (1999) Sequence homology and structural analysis of the Clostridial neurotoxins. J Mol Biol 291 1091-1104
11. JL Middlebrook and DR Franz (1997) Botulinum toxin. FR Sidell, ET Takafuji, DR Franz, DC (Eds) Medical Aspects of Chemical and Biologic Warfare Office of the Surgeon General 643-654
12. JB Park and LL Simpson (2003) Inhalational poisoning by botulinum toxin and inhalation vaccination with its heavy-chain component. Infect Immun 7 1147-1154
13. KF Meyer (1973) The rise and fall of botulism. Calif Med 118 63-64
14. TF Midura and SS Arnon (1976) Infant botulism. Identification of Clostridium botulinum and its toxins in faeces. Lancet 2 934-936
15. J Pickett, B Berg, E Chaplin and MA Brunstetter-Shafer (1976) Syndrome of botulism in infancy: Clinical and electrophysiologic study. N Engl J Med 295 770-772
16. JB Davis, LH Mattman and M Wiley (1951) Clostridium botulinum in a fatal wound infection. JAMA 146 934-936
17. SB Werner, D Passaro, J McGee, et al. (2000) Wound botulism in California, 1951–1998: Recent epidemic in heroin injectors. Clin Infect Dis 3 1018-1024
18. Centers for Disease Control and Prevention (1978) Botulism-United States, 1978. MMWR 28 73-75
19. JK Chia, JB Clark, CA Ryan and M Pollack (1986) Botulism in an adult associated with food-borne intestinal infection with Clostridium botulinum. N Engl J Med 315 239-241
20. PM Griffin, CL Hatheway, RB Rosenbaum and R Sokolow (1997) Endogenous antibody production to botulinum toxin in an adult with intestinal colonization botulism and underlying Crohn's disease. J Infect Dis 175 633-637
21. E Holzer (1962) Botulismus durch inhalation. Med Klin 41 1735-1740
22. DB Cobb, WA Watson and MC Fernandez (2000) Botulism-like syndrome after injection of botulinum toxin. Vet. Hum. Toxicol 42 163
23. United Nations Security Council (1995) Tenth report of the Executive Committee of the Special Commission established by the Secretary-General pursuant to paragraph 9(b)(I) of Security Council Resolution 687 (1991), and paragraph 3 of resolution 699 (1991) on the activities of the Special Commission. United Nations Security Council
24. G Bozheyeva, Y Kunakbayev and D Yeleukenov (1999) Former Soviet biological weapons facilities in Kazakhstan: Past, present, and future. Center for Nonproliferation Studies, Monterey Institute of International Studies Monterey, CA
25. RA Zilinskas (1997) Iraq's biological weapons: The past as future? JAMA 278 418-424
26. R St. John, B Finlay and C Blair (2001) Bioterrorism in Canada: An economic assessment of prevention and postattack exposure. Can J Infect Dis 12 275-284
27. CL Hatheway (1990) Toxigenic Clostridia. Clin Microbiol Rev 3 66-98
28. CL Hatheway (1995) Botulism: The present status of the disease. Curr Top Microbiol Immunol 195 55-75
29. P Aureli, L Fenicia, B Pasolini, et al. (1986) Two cases of type E infant botulism caused by neurotoxigenic Clostridium butyricum in Italy. J Infect Dis 154 207-211
30. LM McCroskey, CL Hatheway, L Fenicia, et al. (1986) Characterization of an organism that produces type E botulinal toxin but which resembles Clostridium butyricum from the feces of an infant with type E botulism. J Clin Microbiol 23 201-202
31. JD Hall, LM McCroskey, BJ Pincomb and CL Hatheway (1985) Isolation of an organism resembling Clostridium barati which produces type F botulinal toxin from an infant with botulism. J Clin Microbiol 21 654-655
32. LM McCroskey, CL Hatheway, BA Woodruff, et al. (1991) Type F botulism due to neurotoxigenic Clostridium baratii from an unknown source in an adult. J Clin Microbiol 29 2618-2620
33. ED Borland, CJ Moryson and GR Smith (1977) Avian botulism and the high prevalence of Clostridium botulinum in the Norfolk Broads. Vet Rec 100 106-109
34. JW Galvin, TJ Hollier, KD Bodinnar and CM Bunn (1985) An outbreak of botulism in wild waterbirds in southern Australia. J Wildl Dis 21 347-350
35. WI Jensen and JI Price (1987) The global importance of type C botulism in wild birds. MW Eklund,(Eds) Avian Botulism: An International Perspective Springfield, Ill.: Charles C. Thomas 33-54
36. GR Smith and RA Milligan (1977) Clostridium botulinum type D in Britain. Vet Rec 100 121-122
37. J Demarchi, C Mourgues, J Orio and AR Prevot (1958) Existence du botulisme de type D. Bull Acad Nat Med 142 580-582
38. AR Prevot, J Terrasse, J Daumail, et al. (1955) Existence en France du botulisme humain de type C. Bull Acad Med 139 355-358. (Paris)
39. DF Gimenez and AS Ciccarelli (1970) Studies on strain 84 of Clostridium botulinum. Zentralbl Bakteriol 215 212-220. [Orig]
40. DF Gimenez and AS Ciccarelli (1976) Clostridium botulinum in Argentina: Present and future. Rev Asoc Argent Microbiol 8 82-91
41. O Sonnabend, W Sonnabend, R Heinzle, et al. (1981) Isolation of Clostridium botulinum type G and identification of type G botulinal toxin in humans: report of five sudden unexpected deaths. J Infect Dis 143 22-27
42. JC Suen, CL Hatheway, AG Steigerwalt and DJ Brenner (1988) Clostridium argentinense, sp. nov: A genetically homogeneous group composed of all strains of Clostridium botulinum toxin type G and some nontoxigenic strains previously identified as Clostridium subterminale or Clostridium hastiforme. Int J Syst Bacteriol 38 375-381
43. CL Hatheway, LM McCroskey, GL Lombard and VR Dowell Jr. (1981) Atypical toxin variant of Clostridium botulinum type B associated with infant botulism. J Clin Microbiol 14 607-611
44. CL Hatheway and LM McCroskey (1987) Examination of feces and serum for diagnosis of infant botulism in 336 patients. J Clin Microbiol 25 2334-2338
45. DF Gimenez (1984) Clostridium botulinum Ba. Zentralbl Bakteriol Hyg 257 68-72
46. JA Santos-Buelga, MD Collins and AK East (1998) Characterization of the genes encoding the botulinum neurotoxin complex in a strain of Clostridium botulinum producing type B and F neurotoxins. Curr Microbiol 37 312-318
47. BR Dasgupta, DA Boroff and E Rothstein (1966) Chromatographic fractionation of the crystalline toxin of Clostridium botulinum type A. Biochem Biophys Res Commun 22 750-756
48. BR DasGupta and DA Boroff (1968) Separation of toxin and hemagglutinin from crystalline toxin of Clostridium botulinum type A by anion exchange chromatography and determination of their dimensions by gel filtration. J Biol Chem 243 1065-1072
49. P Balding, ER Gold, DA Boroff and TA Roberts (1973) Observations on receptor specific proteins. II. Haemagglutination and haemagglutination-inhibition reactions of Clostridium botulinum types A, C, D and E haemagglutinins. Immunology 25 773-782
50. AK East, JM Stacey and MD Collins (1994) Cloning and sequencing of a hemagglutinin component of the botulinum neurotoxin complex encoded by the Clostridium botulinum types A and B. Syst Appl Microbiol 17 306-312
51. R Fujita, Y Fujinaga, K Inoue, et al. (1995) Molecular characterization of two forms of nontoxic-nonhemagglutinin components of Clostridium botulinum type A progenitor toxins. FEBS Lett 376 41-44
52. AK East, M Bhandari, JM Stacey, et al. (1996) Organization and phylogenetic interrelationships of genes encoding components of the botulinum toxin complex in proteolytic Clostridium botulinum types A, B, and F: evidence of chimeric sequences in the gene encoding the nontoxic nonhemagglutinin component. Int J Syst Bacteriol 46 1105-1112
53. I Ohishi, S Sugii and G Sakaguchi (1977) Oral toxicities of Clostridium botulinum toxins in response to molecular size. Infect Immun 16 107-109
54. F Chen, GM Kuziemko and RC Stevens (1998) Biophysical characterization of the stability of the 150-kilodalton botulinum toxin, the nontoxic component, and the 900-kilodalton botulinum toxin complex species. Infect Immun 66 2420-2425
55. A Willems, AK East, PA Lawson and MD Collins (1993) Sequence of the gene coding for the neurotoxin of Clostridium botulinum type A associated with infant botulism: comparison with other Clostridial neurotoxins. Res Microbiol 144 547-556
56. DE Thompson, JK Brehm, JD Oultram, et al. (1990) The complete amino acid sequence of the Clostridium botulinum type A neurotoxin, deduced by nucleotide sequence analysis of the encoding gene. Eur J Biochem 189 73-81
57. T Binz, H Kurazono, M Wille, et al. (1990) The complete sequence of botulinum neurotoxin type A and comparison with other Clostridial neurotoxins. J Biol Chem 265 9153-9158
58. SM Whelan, MJ Elmore, NJ Bodsworth, et al. (1992) Molecular cloning of the Clostridium botulinum structural gene encoding the type B neurotoxin and determination of its entire nucleotide sequence. Appl Environ Microbiol 58 2345-2354
59. H Ihara, T Kohda, F Morimoto, et al. (2003) Sequence of the gene for Clostridium botulinum type B neurotoxin associated with infant botulism, expression of the C-terminal half of heavy chain and its binding activity. Biochim Biophys Acta 1625 19-26
60. D Hauser, MW Eklund, H Kurazono, et al. (1990) Nucleotide sequence of Clostridium botulinum C1 neurotoxin. Nucleic Acids Res 18 4924
61. T Binz, H Kurazono, MR Popoff, et al. (1990) Nucleotide sequence of the gene encoding Clostridium botulinum neurotoxin type D. Nucleic Acids Res 18 5556
62. SM Whelan, MJ Elmore, NJ Bodsworth, et al. (1992) The complete amino acid sequence of the Clostridium botulinum type-E neurotoxin, derived by nucleotide-sequence analysis of the encoding gene. Eur J Biochem 204 657-667
63. DE Thompson, RA Hutson, AK East, et al. (1993) Nucleotide sequence of the gene coding for Clostridium barati type F neurotoxin: Comparison with other Clostridial neurotoxins. FEMS Microbiol Lett 108 175-182
64. K Campbell, MD Collins and AK East (1993) Nucleotide sequence of the gene coding for Clostridium botulinum (Clostridium argentinense) type G neurotoxin: Genealogical comparison with other Clostridial neurotoxins. Biochim Biophys Acta 1216 487-491
65. AM Gibson, NK Modi, TA Roberts, et al. (1987) Evaluation of a monoclonal antibody-based immunoassay for detecting type A Clostridium botulinum toxin produced in pure culture and an inoculated model cured meat system. J Appl Bacteriol 63 217-226
66. S Kozaki, Y Kamata, T Nishiki, et al. (1998) Characterization of Clostridium botulinum type B neurotoxin associated with infant botulism in Japan. Infect Immun 66 4811-4816
67. DB Lacy, W Tepp, AC Cohen, et al. (1998) Crystal structure of botulinum neurotoxin type A and implications for toxicity. Nature Struct Biol 5 898-902
68. MA Hanson and RC Stevens (2000) Cocrystal structure of synaptobrevin-II bound to botulinum neurotoxin type B at 2.0 A resolution. Nat Struct Biol 7 687-692
69. S Eswaramoorthy, D Kumaran and S Swaminathan (2001) Crystallographic evidence for doxorubicin binding to the receptor-binding site in Clostridium botulinum neurotoxin B. Acta Crystallogr D Biol Crystallogr 57 1743-1746
70. JO Dolly, J Black, RS Williams and J Melling (1984) Acceptors for botulinum neurotoxin reside on motor nerve terminals and mediate its internalization. Nature 307 457-460
71. C Montecucco (1986) How do tetanus and botulinum toxins bind to neuronal membranes? Trends Biochem Sci 11 315-317
72. LL Simpson (1980) Kinetic studies on the interaction between botulinum toxin type A and the cholinergic neuromuscular junction. J Pharmacol Expt Ther 212 16-21
73. T Nishiki, Y Tokuyama, Y Kamata, et al. (1996) The high-affinity binding of Clostridium botulinum type B neurotoxin to synaptotagmin II associated with gangliosides GT1b/GD1a. FEBS Lett 378 253-257
74. G Schiavo, F Benfenati, B Poulain, et al. (1992) Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin. Nature 359 832-835
75. G Schiavo, O Rossetto, S Catsicas, et al. (1993) Identification of the nerve terminal targets of botulinum neurotoxin serotypes A, D, and E. J Biol Chem 268 23784-23787
76. G Schiavo, A Santucci, BR Dasgupta, et al. (1993) Botulinum neurotoxins serotypes A and E cleave SNAP-25 at distinct COOH-terminal peptide bonds. FEBS Lett 335 99-103
77. J Blasi, ER Chapman, E Link, et al. (1993) Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25. Nature 365 160-163
78. T Binz, J Blasi, S Yamasaki, et al. (1994) Proteolysis of SNAP-25 by types E and A botulinal neurotoxins. J Biol Chem 269 1617-1620
79. G Schiavo, CC Shone, O Rossetto, et al. (1993) Botulinum neurotoxin serotype F is a zinc endopeptidase specific for VAMP/synaptobrevin. J Biol Chem 268 11516-11519
80. G Schiavo, C Malizio, WS Trimble, et al. (1994) Botulinum G neurotoxin cleaves VAMP/synaptobrevin at a single Ala-Ala peptide bond. J Biol Chem 269 20213-20216
81. S Yamasaki, Y Hu, T Binz, et al. (1994) Synaptobrevin/vesicle-associated membrane protein (VAMP) of Aplysia californica: Structure and proteolysis by tetanus toxin and botulinal neurotoxins type D and F. Proc Natl Acad Sci 9 4688-4692
82. S Yamasaki, T Binz, T Hayashi, et al. (1994) Botulinum neurotoxin type G proteolyses the Ala81-Ala82 bond of rat synaptobrevin 2. Biochem Biophys Res Commun 200 829-835
83. J Blasi, ER Chapman, S Yamasaki, et al. (1993) Botulinum neurotoxin C1 blocks neurotransmitter release by means of cleaving HPC-1/syntaxin. Embo J 12 4821-4828
84. P Foran, GW Lawrence, CC Shone, et al. (1996) Botulinum neurotoxin C1 cleaves both syntaxin and SNAP-25 in intact and permeabilized chromaffin cells: Correlation with its blockade of catecholamine release. Biochemistry 35 2630-2636
85. RB Sutton, D Fasshauer, R Jahn and AT Brunger (1998) Crystal structure of a SNARE complex involved in synaptic exocytosis at 2.4 A resolution. Nature 395 347-353
86. MH Merson and VR Dowell Jr (1973) Epidemiologic, clinical and laboratory aspects of wound botulism. N Engl J Med 289 1005-1010
87. R Wilson, JG Morris Jr., JD Snyder and RA Feldman (1982) Clinical characteristics of infant botulism in the United States: a study of the non-California cases. Pediatr Infect Dis 1 148-150
88. JM Hughes, JR Blumenthal, MH Merson, et al. (1981) Clinical features of types A and B food-borne botulism. Ann Intern Med 95 442-445
89. BA Woodruff, PM Griffin, LM McCroskey, et al. (1992) Clinical and laboratory comparison of botulism from toxin types A, B, and E in the United States, 1975–1988. J Infect Dis 166 1281-1286
90. JC Maroon (1977) Late effects of botulinum intoxication. JAMA 238 129
91. JM Mann, S Martin, R Hoffman and S Marrazzo (1981) Patient recovery from type A botulism: Morbidity assessment following a large outbreak. Am J Public Health 71 266-269
92. H Ehrenreich, CG Garner and TN Witt (1989) Complete bilateral internal ophthalmoplegia as sole clinical sign of botulism: Confirmation of diagnosis by single fibre electromyography. J Neurol 236 243-245
93. SS Arnon (1993) Clinical trial of human botulism immune globulin. BR DasGupta,(Eds) Botulinum and Tetanus Neurotoxins: Neurotransmission and Biomedical Aspects New York: Plenum Press 477-482
94. A de Paiva, FA Meunier, J Molgo, et al. (1999) Functional repair of motor endplates after botulinum neurotoxin type A poisoning: Biphasic switch of synaptic activity between nerve sprouts and their parent terminals. Proc Natl Acad Sci U S A 96 3200-3205
95. PG Foran, N Mohammed, GO Lisk, et al. (2003) Evaluation of the therapeutic usefulness of botulinum neurotoxin B, C1, E, and F compared with the long lasting type A. Basis for distinct durations of inhibition of exocytosis in central neurons. J Biol Chem 278 1363-1371
96. ME St Louis, SH Peck, D Bowering, et al. (1988) Botulism from chopped garlic: Delayed recognition of a major outbreak. Ann Intern Med 108 363-368
97. PA Blake, MA Horwitz, L Hopkins, et al. (1977) Type A botulism from commercially canned beef stew. South Med J 70 5-7
98. M O'Mahony, E Mitchell, RJ Gilbert, et al. (1990) An outbreak of foodborne botulism associated with contaminated hazelnut yoghurt. Epidemiol Infect 104 389-395
99. JE Seals, JD Snyder, TA Edell, et al. (1981) Restaurant-associated type A botulism: Transmission by potato salad. Am J Epidemiol 113 436-444
100. KL Dodds (1990) Restaurant-associated botulism outbreaks in North America. Food Control 1 139-141
101. MS Eisenberg and TR Bender (1976) Botulism in Alaska, 1947 through 1974. Early detection of cases and investigation of outbreaks as a means of reducing mortality. JAMA 235 35-38
102. KF Meyer and BJ Dubovsky (1922) The distribution of the spores of C. botulinum in the United States. J Infect Dis 31 559-594
103. LDS Smith (1978) The occurrence of Clostridium botulinum and Clostridium tetani in the soil of the United States. Health Lab Sci 15 74-80
104. TL Bott, JS Deffner, E McCoy and EM Foster (1966) Clostridium botulinum type E in fish from the Great Lakes. J Bacteriol 91 919-924
105. BQ Ward, BJ Carroll, ES Garrett and GB Reese (1967) Survey of the U.S. Gulf Coast for the presence of Clostridium botulinum. Appl Microbiol 15 629-636
106. M Cherington and S Ginsberg (1971) Type B botulism: Neurophysiologic studies. Neurology 21 43-46
107. M Cherington (1974) Botulism. Ten-year experience. Arch Neurol 30 432-437
108. M Cherington (1998) Clinical spectrum of botulism. Muscle Nerve 21 701-710
109. RA Maselli and N Bakshi (2000) AAEM case report 16. Botulism. American Association of Electrodiagnostic Medicine. Muscle Nerve 23 1137-1144
110. VR Dowell Jr., LM McCroskey, CL Hatheway, et al. (1977) Coproexamination for botulinal toxin and Clostridium botulinum. A new procedure for laboratory diagnosis of botulism. JAMA 238 1829-1832
111. PA Emanuel, J Dang, JS Gebhardt, et al. (2000) Recombinant antibodies: A new reagent for biological agent detection. Biosens Bioelectron 14 751-759
112. AH Peruski, LH Johnson 3rd and LF Peruski Jr (2002) Rapid and sensitive detection of biological warfare agents using time-resolved fluorescence assays. J Immunol Methods 263 35-41
113. JL Ferreira, SJ Eliasberg, MA Harrison and P Edmonds (2001) Detection of preformed type A botulinal toxin in hash brown potatoes by using the mouse bioassay and a modified ELISA test. J AOAC Int 84 1460-1464
114. W Terranova, JG Breman, RP Locey and S Speck (1978) Botulism type B: Epidemiologic aspects of an extensive outbreak. Am J Epidemiol 108 150-156
115. CO Tacket, WX Shandera, JM Mann, et al. (1984) Equine antitoxin use and other factors that predict outcome in type A foodborne botulism. Am J Med 76 794-798
116. WW Schmidt-Nowara, JM Samet and PA Rosario (1983) Early and late pulmonary complications of botulism. Arch Intern Med 143 451-456
117. JM Hughes and CO Tacket (1983) “Sausage poisoning” revisited. Arch Intern Med 143 425-427
118. RG Hibbs, JT Weber, A Corwin, et al. (1996) Experience with the use of an investigational F(ab')2 heptavalent botulism immune globulin of equine origin during an outbreak of type E origin in Egypt. Clin Infect Dis 23 337-340
119. P Amersdorfer, C Wong, S Chen, et al. (1997) Molecular characterization of murine humoral immune response to botulinum neurotoxin type A binding domain as assessed using phage antibody libraries. Infect Immun 65 3743-3752
120. P Amersdorfer and JD Marks (2000) Phage libraries for generation of anti-botulinum scFv antibodies. Methods Mol Biol 145 219-240
121. P Amersdorfer, C Wong, T Smith, et al. (2002) Genetic and immunological comparison of antibotulinum type A antibodies from immune and non-immune human phage libraries. Vaccine 20 1640-1648
122. A Nowakowski, C Wang, DB Powers, et al. (2002) Potent neutralization of botulinum neurotoxin by recombinant oligoclonal antibody. Proc Natl Acad Sci 99 11346-11350
123. RE Black and RA Gunn (1980) Hypersensitivity reactions associated with botulinal antitoxin. Am J Med 69 567-570
124. SS Arnon (1992) Infant botulism. R Feigen, J Cherry,(Eds) Textbook of Pediatric Infectious Diseases Philadelphia: W.B. Saunders 1095-1102
125. LS Siegel (1988) Human immune response to botulinum pentavalent (ABCDE) toxoid determined by a neutralization test and by an enzyme-linked immunosorbent assay. J Clin Microbiol 26 2351-2356
126. MP Byrne and LA Smith (2000) Development of vaccines for prevention of botulism. Biochimie 82 955-966
127. M Rosenbloom, JB Leikin, SN Vogel and ZA Chaudry (2002) Biological and chemical agents: A brief synopsis. Am J Ther 9 5-14
128. B Knight (1979) Ricin—A potent homicidal poison. Br Med J 1 350-351
129. S Mayor (2003) UK doctors warned after ricin poison found in police raid. Br Med J 326 126
130. S Olsnes and JV Kozlov (2001) Ricin. Toxicon 39 1723-1728
131. E Rutenber and JD Robertus (1991) Structure of ricin B-chain at 2.5 A resolution. Proteins 10 260-269
132. Y Endo, K Mitsui, M Motizuki and K Tsurugi (1987) The mechanism of action of ricin and related toxic lectins on eukaryotic ribosomes. The site and the characteristics of the modification in 28 S ribosomal RNA caused by the toxins. J Biol Chem 262 5908-5912
133. Y Endo and K Tsurugi (1987) RNA N-glycosidase activity of ricin A-chain. Mechanism of action of the toxic lectin ricin in eukaryotic ribosomes. J Biol Chem 262 8128-8130
134. RA Greenfield, BR Brown, JB Hutchins, et al. (2002) Microbiological, biological, and chemical weapons of warfare and terrorism. Am J Med Sci 323 326-340
135. JE Smallshaw, A Firan, JR Fulmer, et al. (2002) A novel recombinant vaccine which protects mice against ricin intoxication. Vaccine 20 3422-3427
136. GD Griffiths, GJ Phillips and SC Bailey (1999) Comparison of the quality of protection elicited by toxoid and peptide liposomal vaccine formulations against ricin as assessed by markers of inflammation. Vaccine 17 2562-2568
137. DW Dyer and JJ Iandolo (1982) The staphylococcal enterotoxins—A genetic overview. J Food Safety 3 249-264
138. AC Papageorgiou, HS Tranter and KR Acharya (1998) Crystal structure of microbial superantigen staphylococcal enterotoxin B at 1.5 A resolution: implications for superantigen recognition by MHC class 2 molecules and T-cell receptors. J Mol Biol 277 61-79
139. ML Evenson, MW Hinds, RS Bernstein, et al. (1988) Estimation of human dose of staphylococcal enterotoxin A from a large outbreak of staphylococcal food poisoning involving chocolate milk. Int J Food Microbiol 7 311-316
140. SD Holmberg and PA Blake (1984) Staphylococcal food poisoning in the United States. New facts and old misconceptions. JAMA 251 487-489
141. RD LeClaire, RE Hunt and S Bavari (2002) Protection against bacterial superantigen staphylococcal enterotoxin b by passive vaccination. Infect Immun 70 2278-2281
142. JW Boles, LM Pitt, RD LeClaire, et al. (2003) Generation of protective immunity by inactivated recombinant staphylococcal enterotoxin B vaccine in nonhuman primates and identification of correlates of immunity. Clin Immun 108 51-59
143. JL McDonel (1986) Toxins of Clostridium perfringens types A, B, C, D, and E. Oxford: Pergamon Press
144. O Miyamoto, J Minami, T Toyoshima, et al. (1998) Neurotoxicity of Clostridium perfringens epsilon-toxin for the rat hippocampus via the glutaminergic system. Infect Immun 66 2501-2508